This fact sheet by the GHTC describes the important role USAID plays in global health research and development, as well as offers policy recommendations for how the agency and Congress can continue to ensure the development of global health tools for low-resourced settings.
Each year, the GHTC releases a policy report that includes recommendations for how US policymakers can continue to advance innovation and save lives around the world. A print summary version (2.7 MB PDF) of the report is also available.
The US Agency for International Development has awarded the CAPRISA 004 tenofovir gel trial the Science and Technology Pioneers Prize. The tenofovir gel is the first microbicide shown to effectively and safely reduce HIV transmission in women. FHI 360 was one of the collaborating partners on the trial.